The latest episode of Motley Fool Hidden Gems Investing, hosted by Tyler Crowe and featuring Rachel Warren and Travis Hoyam, delved into the recent "fever pitch" surrounding AI development and investment trends.
The primary discussion centered on the seemingly sudden calls from AI leaders like Sam Altman of OpenAI and Dario Amodei of Anthropic to slow down the development of frontier models, citing safety concerns. This follows several employees leaving Anthropic and OpenAI over similar worries. Crowe introduced a "cynical view," suggesting that this timing might be driven by financial pressures and the impending IPOs of these companies, rather than purely altruistic safety motives.
Rachel Warren echoed this nuanced perspective, stating that while genuine safety concerns likely exist, there are also significant financial calculations at play. She pointed out that OpenAI is projected to face a $14 billion loss in 2026, with cumulative losses potentially reaching $44 billion by 2028. Anthropic, meanwhile, has locked in a staggering $517 billion in compute commitments, equivalent to the capacity of a dozen nuclear reactors. Warren highlighted that early investors like Bridgewater Associates' Greg Jensen, who has stakes in OpenAI and Anthropic, are also vocal about catastrophic AI risks, suggesting a potential motivation to influence regulation that could benefit larger, established players by pricing out open-source communities and smaller competitors.
Travis Hoyam agreed, noting the "cognitive dissonance" of AI leaders warning about dangers while simultaneously pushing development. He suggested that all perspectives—genuine concern, regulatory capture, and even "crying wolf"—could hold truth. Hoyam emphasized that AI developers themselves don't fully understand how their creations work, leading to an almost "religious view" of the technology. He also speculated whether an undisclosed "oopsie" at one of these labs might be behind the sudden, coordinated calls for caution. The hosts concluded that this situation mirrors the "Silicon Valley playbook" where early dominance is followed by calls for regulation that inadvertently create moats for the giants.
Shifting to broader investment trends, Travis Hoyam expressed concern about the consumer sector. Despite the market nearing all-time highs, he noted weakness in shoe, apparel, and restaurant stocks, with consumer discretionary being the worst-performing sector year-to-date (-5.3%). Rising gas prices and struggling housing markets could further impact consumer spending. However, he sees potential opportunities in beaten-down stocks trading at 10-15 times earnings.
Rachel Warren, on the other hand, highlighted her excitement about AI's application in healthcare. She emphasized its role in refining drug development, discovery, and clinical trials, speeding up processes that typically take over a decade and billions of dollars with high failure rates. AI acts as an "automation and data engine" to overcome bottlenecks. Examples include Moderna's Maestro system for personalized cancer vaccines and Crystal Biotech using AI for real-time quality control in gene therapy production. While acknowledging initial fears about AI killing Contract Research Organizations (CROs), Warren believes that tech-fluent CROs like MedPace will thrive due to an increased volume of drug candidates from accelerated discovery.
Finally, addressing a mailbag question from James in Atlanta about dividends in growth stocks, Travis Hoyam explained that dividends serve as a communication tool for companies to attract specific investor pools. He also suggested that dividends often indicate a company has fewer compelling internal investment opportunities, characteristic of mature businesses. While advocating for an irregular dividend model (where payouts fluctuate based on profitability, similar to private businesses), he noted the market's aversion to such volatility.
Rachel Warren viewed dividends as a "discipline signal," showing that a cash-rich company rewards shareholders. They provide predictable income for reinvestment and broaden the investor base, as many funds are mandated to hold dividend-paying stocks. While acknowledging potential tax inefficiencies compared to buybacks and the risk of cuts, she sees value in stable dividends from companies with strong profits and favorable payout ratios, especially for a diversified portfolio.